Gene analysis (telomerase reverse transcriptase) targeted sequence analysis
Medicare pricing data for 36 providers across 4 states
Note: These costs reflect the Medicare physician/supplier component. Hospital facility fees are billed separately and can be 2-5x the physician fee.
💡 What You Should Know
Gene analysis (telomerase reverse transcriptase) targeted sequence analysis (HCPCS code 81345) is a medical procedure billed to Medicare. The average Medicare-allowed cost is $181.49, but hospitals typically charge $204.50 — a 1.1x markup. Prices vary significantly by state and provider.
🏷️ Typical Out-of-Pocket Cost
Medicare patients typically pay about 20% of the allowed amount as coinsurance. Based on the average allowed cost of $181.49, your out-of-pocket cost would be approximately $36.30. Actual costs depend on your specific plan, deductible, and whether you've met your annual out-of-pocket maximum.
What Hospitals Charge vs. What Medicare Pays
Hospitals charge 1.1x more than what Medicare allows for this procedure. Medicare actually pays $181.49 on average.
Cost by State
Medicare-allowed amounts vary significantly by state
| State | Allowed Cost | Hospital Charge | Providers | Services | vs. National |
|---|---|---|---|---|---|
| Florida | $182 | $204 | 21 | 16,497 | +0.0% |
| New Jersey | $182 | $185 | 2 | 29 | +0.0% |
| Pennsylvania | $182 | $185 | 2 | 18 | +0.0% |
| Texas | $180 | $237 | 4 | 14 | -0.6% |
⚠️ Important: These costs reflect the Medicare physician/supplier component. Hospital facility fees may be billed separately. Total out-of-pocket costs may be higher.
💊 Need post-procedure medications? Check costs on OpenPrescriber